期刊文献+

以肠道外症状为首发表现的结肠癌47例临床分析 被引量:2

Clinical Analysis on Extra-Intestinal Symptoms as the First Symptoms of 47 Patients with Colon Cancer
原文传递
导出
摘要 目的:分析以肠道外症状为首发表现的结肠癌临床特征,旨在提高结肠癌诊治水平。方法:收集我院1994年1月至2008年1月间以肠道外症状为首发表现的结肠癌47例,对其临床特点进行回顾性分析。结果:47例以肠道外症状为首发表现的结肠癌中位发病年龄为65岁;贫血症状多见,占78.7%(37/47),长期低热3例,肝转移瘤4例,肺转移瘤2例,皮肌炎1例;肿瘤多发生于右半结肠,占74.5%(35/47);病理类型:乳头状腺癌为主,占61.7%(29/47);Dukes分期:B期占44.7%(21/47),C期占42.6%(20/47);结肠镜是重要诊断方法,结肠镜与钡灌肠有互补优势;手术是主要治疗手段,综合治疗可延长患者生存期。结论:以肠道外症状为首发表现的结肠癌以贫血多见,病变多位于右半结肠,结肠镜是主要确诊方法,以手术为主的综合治疗可改善患者预后。 目的:分析以肠道外症状为首发表现的结肠癌临床特征,旨在提高结肠癌诊治水平。方法:收集我院1994年1月至2008年1月间以肠道外症状为首发表现的结肠癌47例,对其临床特点进行回顾性分析。结果:47例以肠道外症状为首发表现的结肠癌中位发病年龄为65岁;贫血症状多见,占78.7%(37/47),长期低热3例,肝转移瘤4例,肺转移瘤2例,皮肌炎1例;肿瘤多发生于右半结肠,占74.5%(35/47);病理类型:乳头状腺癌为主,占61.7%(29/47);Dukes分期:B期占44.7%(21/47),C期占42.6%(20/47);结肠镜是重要诊断方法,结肠镜与钡灌肠有互补优势;手术是主要治疗手段,综合治疗可延长患者生存期。结论:以肠道外症状为首发表现的结肠癌以贫血多见,病变多位于右半结肠,结肠镜是主要确诊方法,以手术为主的综合治疗可改善患者预后。
出处 《现代生物医学进展》 CAS 2011年第S1期4713-4715,共3页 Progress in Modern Biomedicine
关键词 结肠癌 肠道外症状 诊断 治疗 Colon cancer Extra-intestinal symptoms Diagnosis Treatment
  • 相关文献

参考文献12

  • 1章国星,操寄望.MACC1与结肠癌的研究进展[J].现代生物医学进展,2010,10(19):3792-3794. 被引量:6
  • 2杨玉恒,王东江,董艳彩.以贫血首诊的结肠癌误诊106例分析[J].中国误诊学杂志,2007,7(7):1435-1435. 被引量:6
  • 3徐丽莹,周云峰,邱大胜.Correlation between Calcified Liver Metastases and Histopathology of Primary Colorectal Carcinoma in Chinese[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2010,30(6):815-818. 被引量:2
  • 4Tentes AA,,Korakianitis OS,Kakolyris S,et al.Differences betweenright-and left-sided colon carcinomas. J BUON . 2010
  • 5Catenacci DV,Kozloff M,Kindler HL.Personalized colon cancer carein 2010. Seminars in Oncology . 2011
  • 6Efremidou EI,Liratzopoulos N,Papageorgiou SM,et al.Colorectalcarcinoma:correlation between age,gender and subsite distribution. Chirurgia . 2008
  • 7Fraser CG,McDonald PJ,Colford L,et al.Experience with a wipeguaiac-based faecal occult blood test as an alternative test in a bowelscreening programme. Journal of Medical Screening . 2010
  • 8Zhang SZ.Necessity and feasibility of screening for colorectal cancerin China. Zhonghua Wei Chang Wai Ke Za Zhi . 2011
  • 9WB Al-Refaie,HM Parsons,EB Habermann,M Kwaan,MP Spencer,WG Henderson,DA Rothenberger.Operative outcomes beyond 30-day mortality: colorectal cancer surgery in the oldest old. Annals of Surgery . 2011
  • 10Hu H,Sun L,Guo C,et al.Tumor cell-microenvironment interactionmodels coupled with clinical validation reveal CCL2 and SNCG astwo predictors of colorectal cancer hepatic metastasis. Clinical Cancer Research . 2009

二级参考文献55

  • 1李宏武,单吉贤.人大肠癌组织肝细胞生长因子及其受体c-met的表达[J].世界华人消化杂志,2004,12(9):2199-2201. 被引量:13
  • 2Parkin DM, Bray F, Ferlay J, Pisani P, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin ,2005, 55(2): 74-108.
  • 3O'Connell JB, Maggard MA, Ko CY, et al. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging [J]. J Natl Cancer Inst ,2004,96(19):1420-5.
  • 4Ulrike Stein, Wolfgang Walther, Franziska Arlt, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis [J]. Nat Med ,2009a,15(1):59-67.
  • 5Kokoszy n ska K, Kryn ski J, Rychlewski L, et al. Unexpected domain composition of MACC1 links MET signaling and apoptosis [J]. Acta Biochim Pol,2009,56(2):317-23.
  • 6Zhang J, Xu LG, Hart KJ, et al. Identification of a ZU5 and death domain-containing inhibitor ofNF-kap-paB[J]. J Biol Chem ,2004,279 (17): 17819-17825.
  • 7Sikorski AF, Hanus-Lorenz B, Jezierski A,et al. Interaction:of membrane skeletal proteins with membrane lipid domain [J]. Acta Biochim Polon, 2000, 47(3): 565-578.
  • 8Ipsaro J J, Huang L, Mondragon A. Structures of the spectrin-ankyrin interaction binding domains [J]. Blood ,2009,113(22): 5385-5393.
  • 9Ulrike Stein, Mathias Dahlmann, Wolfgang Walther. MACC1 - more than metastasis ? Facts and predictions about a novel gene [J]. J Mol Med ,2010,88(1): 11-18.
  • 10Reed JC, Doctor KS, Godzik A .The domains of apoptosis: a genomics perspective [J]. Sci STKE, 2004,2004(239):re9.

共引文献11

同被引文献22

  • 1Mishima H, Ikenaga M, Tsujinaka T, et al. FOLFOX [J]. GanToKagaku Ryoho,2006,33(7):911-914.
  • 2Cummings LC, Delaney CP, Cooper GS. Laparoscopic versus opencolectomy for colon cancer in an older population: a cohort study [J].World J Surg Oncol,2012,10:31.
  • 3Tanis E, van Geloven AA, Bemelman WA, et al. A comparison ofshort-term outcome after laparoscopic, transverse, and midlineright-sided colectomy[J]. Int J Colorectal Dis,2012 Jan 17.
  • 4Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial oflaparoscopic-assisted resection of colorectal carcinoma: 3-year resultsof the UK MRC CLASICC Trial Group[J]. J Clin Oncol,2007,25(21):3061-3068.
  • 5Khan JS, Hemandas AK, Flashman KG, et al. Clinical outcome oflaparoscopic and open colectomy for right colonic carcinoma [J]. AnnRColl Surg Engl,2011,93(8):603-607.
  • 6Stucky CC, Pockaj BA, Novotny PJ, et al. Long-term follow-up andindividual item analysis of quality of life assessments related tolaparoscopic-assisted colectomy in the COST trial 93-46-53 (INT0146 ) [J]. Ann Surg Oncol,2011,18(9):2422-2431.
  • 7Ohtani H,Tamamori Y,Arimoto Y,et al. A meta-analysis of theshort- and long-term results of randomized controlled trials thatcompared laparoscopy-assisted and open colectomy for colon cancer[J].JCancers2012,3:49-57.
  • 8Bilimoria KY, Bentrem DJ, Merkow RP, et al. Laparoscopic-assistedvs. open colectomy for cancer: comparison of short-term outcomesfrom 121 hospitals[J]. J Gastrointest Surg,2008,12(11):2001-2009.
  • 9Kuhry E, Schwenk W, Gaupset R, et al. Long-term outcome oflaparoscopic surgery for colorectal cancer:a cochrane systematicreview of randomised controlled trials [J]. Cancer Treat Rev,2008,34(6):498-504.
  • 10Varela JE, Asolati M, Huerta S,et al. Outcomes of laparoscopic andopen colectomy at academic centers[J]. Am J Surg,2008,196(3):403-406.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部